Product Information
GNP LORATADINE-D 12 HR TABLET is a generic product labeled by AmerisourceBergen, priced at $0.7818 per EA under NDC 46122045514. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Jan 30, 2003.
Strength
5; 120 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122045514
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINE; PSEUDOEPHEDRINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076050FDA Approved
1/30/2003
On Market Since
4/23/2018
Pharmacological Classes
Price Statistics
The NADAC for GNP LORATADINE-D 12 HR TABLET has been published 54 times since Sep 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7818 per EA |
|---|---|
| All-time high | $0.8018 (Jun 10, 2026) |
| All-time low | $0.7818 (Sep 23, 2026) |
| 52-week high | $0.8018 |
| 52-week low | $0.7818 |
| Median price | $0.7950 |
| Average price | $0.7931 |
| Largest weekly change | -1.1% (Jul 22, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
loratadine, Pseudoephedrine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP LORATADINE-D 12 HR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP LORATADINE-D 12 HR TABLET, manufactured by AmerisourceBergen, is $0.7818 per EA (NDC 46122045514), effective Sep 30, 2026.
How has the price of GNP LORATADINE-D 12 HR TABLET changed over time?
Over the history we have for it, the NADAC for GNP LORATADINE-D 12 HR TABLET has held within roughly two percent of its current level. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for GNP LORATADINE-D 12 HR TABLET?
Since Sep 24, 2025, the NADAC for GNP LORATADINE-D 12 HR TABLET has ranged from a low of $0.7818 (Sep 23, 2026) to a high of $0.8018 (Jun 10, 2026), with a median of $0.7950 per EA.
Are there cheaper alternatives to GNP LORATADINE-D 12 HR TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP LORATADINE-D 12 HR TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP LORATADINE-D 12 HR TABLET?
GNP LORATADINE-D 12 HR TABLET (NDC 46122045514) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.